A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors

NCT02829099 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Neoplasms

Interventions

DRUG: JNJ-64457107

Sponsor

Janssen Research & Development, LLC